Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMVT

Immunovant (IMVT)

Immunovant Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMVT
DateTimeSourceHeadlineSymbolCompany
30/05/202406:36Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IMVTImmunovant Inc
30/05/202406:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
30/05/202406:01GlobeNewswire Inc.Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024NASDAQ:IMVTImmunovant Inc
25/05/202406:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
25/05/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
25/05/202406:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
25/05/202406:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
12/03/202422:30GlobeNewswire Inc.Immunovant Awarded U.S. Patent for IMVT-1402NASDAQ:IMVTImmunovant Inc
24/02/202408:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
24/02/202408:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
24/02/202408:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
15/02/202400:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMVTImmunovant Inc
12/02/202423:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMVTImmunovant Inc
12/02/202423:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
30/01/202408:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
20/01/202408:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
16/01/202423:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
13/01/202408:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
10/01/202408:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
10/01/202408:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
10/01/202400:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
04/01/202400:00GlobeNewswire Inc.Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMVTImmunovant Inc
21/12/202309:40Dow Jones NewsImmunovant Gets Positive Data From Graves' Disease Treatment TrialNASDAQ:IMVTImmunovant Inc
21/12/202308:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
21/12/202308:30GlobeNewswire Inc.Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ DiseaseNASDAQ:IMVTImmunovant Inc
21/12/202308:30GlobeNewswire Inc.Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ DiseaseNASDAQ:IMVTImmunovant Inc
28/11/202323:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
28/11/202323:00GlobeNewswire Inc.Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class PotentialNASDAQ:IMVTImmunovant Inc
28/11/202323:00GlobeNewswire Inc.Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class PotentialNASDAQ:IMVTImmunovant Inc
25/11/202306:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
 Showing the most relevant articles for your search:NASDAQ:IMVT